1889 Stock Overview
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sanai Health Industry Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.014 |
| 52 Week High | HK$0.074 |
| 52 Week Low | HK$0.012 |
| Beta | -0.21 |
| 11 Month Change | -17.65% |
| 3 Month Change | -50.00% |
| 1 Year Change | -79.10% |
| 33 Year Change | n/a |
| 5 Year Change | -88.14% |
| Change since IPO | -99.29% |
Recent News & Updates
Sanai Health Industry Group Company Limited (HKG:1889) Might Not Be As Mispriced As It Looks After Plunging 29%
Jun 28
Is Sanai Health Industry Group (HKG:1889) Using Too Much Debt?
Jun 07Positive Sentiment Still Eludes Sanai Health Industry Group Company Limited (HKG:1889) Following 26% Share Price Slump
Apr 03Recent updates
Sanai Health Industry Group Company Limited (HKG:1889) Might Not Be As Mispriced As It Looks After Plunging 29%
Jun 28Is Sanai Health Industry Group (HKG:1889) Using Too Much Debt?
Jun 07Positive Sentiment Still Eludes Sanai Health Industry Group Company Limited (HKG:1889) Following 26% Share Price Slump
Apr 03Improved Earnings Required Before Sanai Health Industry Group Company Limited (HKG:1889) Shares Find Their Feet
Jan 23What Sanai Health Industry Group Company Limited's (HKG:1889) 35% Share Price Gain Is Not Telling You
May 15We Like The Quality Of Sanai Health Industry Group's (HKG:1889) Earnings
Sep 23Shareholder Returns
| 1889 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -6.7% | -0.8% | -0.02% |
| 1Y | -79.1% | -6.1% | -5.2% |
Return vs Industry: 1889 underperformed the Hong Kong Pharmaceuticals industry which returned -6.1% over the past year.
Return vs Market: 1889 underperformed the Hong Kong Market which returned -5.2% over the past year.
Price Volatility
| 1889 volatility | |
|---|---|
| 1889 Average Weekly Movement | 13.4% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 13.8% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 1889's share price has been volatile over the past 3 months.
Volatility Over Time: 1889's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 68 | n/a | www.1889hk.com |
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services.
Sanai Health Industry Group Company Limited Fundamentals Summary
| 1889 fundamental statistics | |
|---|---|
| Market cap | HK$53.51m |
| Earnings (TTM) | HK$20.34m |
| Revenue (TTM) | HK$133.27m |
2.6x
P/E Ratio0.4x
P/S RatioIs 1889 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1889 income statement (TTM) | |
|---|---|
| Revenue | CN¥122.10m |
| Cost of Revenue | CN¥86.97m |
| Gross Profit | CN¥35.13m |
| Other Expenses | CN¥16.50m |
| Earnings | CN¥18.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0049 |
| Gross Margin | 28.77% |
| Net Profit Margin | 15.26% |
| Debt/Equity Ratio | 22.6% |
How did 1889 perform over the long term?
See historical performance and comparison